SB
ALPS Medical Breakthroughs ETF (SBIO)
LSE
76.39
+0.56 (+0.75%)
Closed
Aug 21, 2026
Day's Range
75.0076.50
52 wk Range
48.1476.96
Overview - SBIO - ALPS Medical Breakthroughs ETF
Key Statistics
Valuation
P/E (Trailing)
‪0.26‬
Price stats
50-Day Avg
‪67.97‬
200-Day Avg
‪62.52‬
Peers - SBIO - ALPS Medical Breakthroughs ETF
Peer Comparison
Compared with companies in Specialty Chemicals listed on LSE.
- SBSBIOLSEALPS Medical Breakthroughs ETF+35.47%52-week change0.27P/E (Trailing)—Profit Margin
- 3DESLSEWisdomTree DAX 3x Daily Short+98.83%52-week change—P/E (Trailing)—Profit Margin
- 3LESLSEWisdomTree EURO STOXX 50 3x Daily Short+98.52%52-week change—P/E (Trailing)—Profit Margin
- 3SISLSEWisdomTree Silver 3x Daily Short+98.31%52-week change—P/E (Trailing)—Profit Margin
- 3BRSLSEWisdomTree Brent Crude Oil 3x Daily Short+95.37%52-week change—P/E (Trailing)—Profit Margin
- 3HCSLSEWisdomTree Copper 3x Daily Short+85.86%52-week change—P/E (Trailing)—Profit Margin
- 3ADELSELeverage Shares 3x AMD ETP+77.97%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - SBIO - ALPS Medical Breakthroughs ETF
About
ALPS Medical Breakthroughs ETF is an exchange-traded fund that provides targeted exposure to small- and mid-cap biotechnology companies advancing innovative treatments through clinical development. The fund tracks the S-Network Medical Breakthroughs Index, which comprises US-listed biotech firms with one or more drugs…
SectorBasic Materials
IndustrySpecialty Chemicals
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
